Abstract

A systematic review was conducted to evaluate the efficacy of vaccination to reduce Salmonella prevalence in market weight finisher swine. A search of online databases and selected conference proceedings was conducted to identify relevant studies. The review process followed relevance screening, methodological quality assessment, and data extraction. Although multiple outcomes were frequently reported, only outcomes describing culture of Salmonella were extracted. Five clinical trials and 23 challenge studies were considered likely relevant to the review as they described vaccination to reduce Salmonella in swine. Five clinical trials reported vaccination was associated with reduced isolation of Salmonella in market weight pigs, however, information required to assess the internal validity of the study was often not described in the manuscripts. All challenge studies assessed vaccine efficacy in pigs aged <15 weeks reducing the relevance of results to the review which focused on market weight pigs. Only five of the 23 challenge studies reported the majority of information necessary to evaluate the quality of vaccine studies. Given large variability in population type, sample size, type of vaccine, dose and dosing regimens, and type of outcomes observed, pooled data analysis was not possible, and therefore, a qualitative synthesis of the studies was conducted. Available evidence suggests that vaccination is associated with reduced Salmonella prevalence in swine at or near harvest; however, this conclusion is based on studies with design and reporting deficiencies that could potentially indicate biases with the outcome.